Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Maikel Izquierdo"'
Autor:
Maikel Izquierdo, De Lin, Sandra O'Neill, Lauren A Webster, Christy Paterson, John Thomas, Mirtha Elisa Aguado, Enrique Colina Araújo, Daniel Alpízar-Pedraza, Halimatu Joji, Lorna MacLean, Anthony Hope, David W Gray, Martin Zoltner, Mark C Field, Jorge González-Bacerio, Manu De Rycker
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 18, Iss 2, p e0011956 (2024)
BackgroundChagas disease is caused by the protozoan parasite Trypanosoma cruzi and leads to ~10,000 deaths each year. Nifurtimox and benznidazole are the only two drugs available but have significant adverse effects and limited efficacy. New chemothe
Externí odkaz:
https://doaj.org/article/eda16b548238447697b8e6f336b5e1ca
Autor:
Jorge González-Bacerio, Maikel Izquierdo, Mirtha Elisa Aguado, Ana C. Varela, Maikel González-Matos, Maday Alonso del Rivero
Publikováno v:
Microbial Cell, Vol 8, Iss 10, Pp 239-246 (2021)
Several microbial metalo-aminopeptidases are emerging as novel targets for the treatment of human infectious diseases. Some of them are well validated as targets and some are not; some are essential enzymes and others are important for virulence and
Externí odkaz:
https://doaj.org/article/6d46b80827814f7c83550a392acbfd4b
Autor:
Jorge González-Bacerio, Irina Arocha, Mirtha Elisa Aguado, Yanira Méndez, Sabrina Marsiccobetre, Maikel Izquierdo, Daniel G. Rivera, Katherine Figarella, Néstor L. Uzcátegui
Publikováno v:
Life, Vol 11, Iss 10, p 1037 (2021)
Chagas disease, caused by the kinetoplastid parasite Trypanosoma cruzi, is a human tropical illness mainly present in Latin America. The therapies available against this disease are far from ideal. Proteases from pathogenic protozoan have been consid
Externí odkaz:
https://doaj.org/article/76ac9f2e5b3e4002a1b154edd177f810
Autor:
Jorge González-Bacerio, Mirtha Elisa Aguado, Maikel Izquierdo, Maikel González-Matos, Ana C. Varela, Yanira Méndez, Maday Alonso del Rivero, Daniel G. Rivera
Publikováno v:
Current Drug Targets. 24:416-461
Background: Parasitic human infectious diseases are a worldwide health problem due to the increased resistance to conventional drugs. For this reason, the identification of novel molecular targets and the discovery of new chemotherapeutic agents are
Autor:
Maikel González-Matos, Ana C. Varela, Maday Alonso del Rivero, Mirtha Elisa Aguado, Jorge González-Bacerio, Maikel Izquierdo
Publikováno v:
Microbial Cell
Microbial Cell, Vol 8, Iss 10, Pp 239-246 (2021)
Microbial Cell, Vol 8, Iss 10, Pp 239-246 (2021)
Several microbial metalo-aminopeptidases are emerging as novel targets for the treatment of human infectious diseases. Some of them are well validated as targets and some are not; some are essential enzymes and others are important for virulence and
Autor:
Martin Zoltner, De Lin, Jorge González-Bacerio, Maikel Izquierdo, David W. Gray, Sandra O’Neill, Anthony G. Hope, Mark C. Field, Lauren A. Webster
Publikováno v:
SLAS Discovery. 25:1064-1071
Leucyl aminopeptidases (LAPs) are involved in multiple cellular functions, which, in the case of infectious diseases, includes participation in the pathogen-host cell interface and pathogenesis. Th...
Autor:
Sabrina Marsiccobetre, Mirtha Elisa Aguado, Katherine Figarella, Yanira Méndez, Irina Arocha, Daniel G. Rivera, Néstor L. Uzcátegui, Jorge González-Bacerio, Maikel Izquierdo
Publikováno v:
Life, Vol 11, Iss 1037, p 1037 (2021)
Life
Volume 11
Issue 10
Life
Volume 11
Issue 10
Chagas disease, caused by the kinetoplastid parasite Trypanosoma cruzi, is a human tropical illness mainly present in Latin America. The therapies available against this disease are far from ideal. Proteases from pathogenic protozoan have been consid
Autor:
Pedro A. Valiente, Maday Alonso del Rivero, Yoanna María Alvarez-Ginarte, Aldrin V. Vasco, Carmen Soto, Yanira Méndez, Tamara Rojas, Bernhard Westermann, Idalia Pérez, German De Armas, Lena de León, Jorge González-Bacerio, Maikel Izquierdo, William L. Scott, Mario E. Valdés-Tresanco, Daniel G. Rivera
Publikováno v:
European Journal of Medicinal Chemistry. 163:481-499
The Escherichia coli neutral M1-aminopeptidase (ePepN) is a novel target identified for the development of antimicrobials. Here we describe a solid-phase multicomponent approach which enabled the discovery of potent ePepN inhibitors. The on-resin pro
Autor:
Maikel González-Matos, Juan F. Quintana, Jorge González-Bacerio, Maikel Izquierdo, Mirtha Elisa Aguado, Mark C. Field
Publikováno v:
Protein expression and purification. 183
The Leishmania major leucyl-aminopeptidase (LAPLm), a member of the M17 family of proteases, is a potential drug target for treatment of leishmaniasis. To better characterize enzyme properties, recombinant LAPLm (rLAPLm) was expressed in Escherichia
Autor:
Maikel, Izquierdo, De, Lin, Sandra, O'Neill, Martin, Zoltner, Lauren, Webster, Anthony, Hope, David W, Gray, Mark C, Field, Jorge, González-Bacerio
Publikováno v:
SLAS discovery : advancing life sciences RD. 25(9)
Leucyl aminopeptidases (LAPs) are involved in multiple cellular functions, which, in the case of infectious diseases, includes participation in the pathogen-host cell interface and pathogenesis. Thus, LAPs are considered good candidate drug targets,